Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data

PURPOSE: To identify baseline prognostic factors for survival in patients with disease progression, during or after chemotherapy for the treatment of advanced gastric or gastroesophageal junction (GEJ) cancer. MATERIALS AND METHODS: We pooled data from patients randomized between 2009 and 2012 in 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Charles S., Muro, Kei, Tomasek, Jiri, Van Cutsem, Eric, Cho, Jae Yong, Oh, Sang-Cheul, Safran, Howard, Bodoky, György, Chau, Ian, Shimada, Yasuhiro, Al-Batran, Salah-Eddin, Passalacqua, Rodolfo, Ohtsu, Atsushi, Emig, Michael, Ferry, David, Chandrawansa, Kumari, Hsu, Yanzhi, Sashegyi, Andreas, Liepa, Astra M., Wilke, Hansjochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489542/
https://www.ncbi.nlm.nih.gov/pubmed/28680718
http://dx.doi.org/10.5230/jgc.2017.17.e16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5489542/
https://www.ncbi.nlm.nih.gov/pubmed/28680718
http://dx.doi.org/10.5230/jgc.2017.17.e16

Ejemplares similares